Market Cap ₹621937 Cr.
Stock P/E 15.2
P/B 6.4
Current Price ₹983.3
Book Value ₹ 154.4
Face Value 10
52W High ₹1221.5
Dividend Yield 1.02%
52W Low ₹ 737
Life Insurance Corporation of India offers life insurance products in India, Fiji, Mauritius, and the UK. It provides individual projects, which includes collaborating coverage products; and non-participating products comprising savings coverage, term coverage, health insurance, annuity and pension, and unit-linked insurance merchandise; special merchandise for women and children, micro coverage merchandise; and riders, an add-on covers to the base policy to facilitate additional advantages linked to the accident, vital infection, and demise and premium waiver advantage. The organization additionally provides group products, including group term coverage, group savings coverage, group savings pension, and group annuity products. Life Insurance Corporation of India was established in 1956 and is primarily based in Mumbai, India.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
#(Fig in Cr.) | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 98805 | 132632 | 112297 | 132223 | 98755 | 107877 | 117432 | 152767 | 114230 | 120326 |
Other Income | 70985 | 90506 | 85688 | 69411 | 91525 | 95444 | 96828 | 100198 | 98723 | 111601 |
Total Income | 169791 | 223138 | 197985 | 201634 | 190280 | 203321 | 214260 | 252965 | 212953 | 231926 |
Total Expenditure | 168369 | 202373 | 195046 | 189481 | 180168 | 194563 | 204745 | 238410 | 202145 | 224532 |
Operating Profit | 1421 | 20765 | 2939 | 12154 | 10113 | 8759 | 9515 | 14555 | 10808 | 7394 |
Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit Before Tax | 1421 | 20765 | 2939 | 12154 | 10113 | 8759 | 9515 | 14555 | 10808 | 7394 |
Provision for Tax | 1481 | 5452 | -2458 | 991 | 1461 | 1181 | 1424 | 2031 | 1629 | 1145 |
Profit After Tax | -60 | 15313 | 5397 | 11163 | 8651 | 7577 | 8092 | 12524 | 9179 | 6249 |
Adjustments | 662 | 542 | 952 | 2028 | 984 | 453 | 1377 | 1257 | 1365 | 1480 |
Profit After Adjustments | 603 | 15854 | 6349 | 13191 | 9635 | 8030 | 9469 | 13782 | 10544 | 7729 |
Adjusted Earnings Per Share | 1 | 25.1 | 10 | 20.9 | 15.2 | 12.7 | 15 | 21.8 | 16.7 | 12.2 |
#(Fig in Cr.) | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM |
---|---|---|---|---|---|---|---|
Net Sales | 339972 | 382476 | 405398 | 429501 | 475957 | 476831 | 504755 |
Other Income | 230838 | 263130 | 298281 | 294925 | 315157 | 380087 | 407350 |
Total Income | 570810 | 645605 | 703679 | 724425 | 791114 | 856919 | 912104 |
Total Expenditure | 567669 | 644929 | 689936 | 706540 | 744236 | 811931 | 869832 |
Operating Profit | 3141 | 677 | 13743 | 17885 | 46878 | 44988 | 42272 |
Interest | 41 | 58 | 114 | 87 | 77 | 128 | 0 |
Depreciation | 429 | 779 | 417 | 436 | 466 | 466 | 0 |
Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit Before Tax | 2642 | 2719 | 2983 | 4165 | 36081 | 41057 | 42272 |
Provision for Tax | 15 | 8 | 9 | 40 | 84 | 141 | 6229 |
Profit After Tax | 2627 | 2710 | 2974 | 4125 | 35997 | 40916 | 36044 |
Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 5479 |
Profit After Adjustments | 2627 | 2710 | 2974 | 4125 | 35997 | 40916 | 41524 |
Adjusted Earnings Per Share | 4.2 | 4.3 | 4.7 | 6.5 | 0 | 0 | 65.7 |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Sales CAGR | 0% | 6% | 7% | 0% |
Operating Profit CAGR | -4% | 48% | 70% | 0% |
PAT CAGR | 14% | 140% | 73% | 0% |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Share Price CAGR | 32% | NA% | NA% | NA% |
ROE Average | 63% | 78% | 114% | 139% |
ROCE Average | 63% | 78% | 47% | 40% |
#(Fig in Cr.) | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|
Shareholder's Funds | 986 | 1088 | 6905 | 11365 | 46545 | 83092 |
Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 |
Borrowings | 269401 | 253414 | 4 | 1 | 0 | 0 |
Other Non-Current Liabilities | 3116583 | 3180303 | 3754444 | 4186117 | 4487268 | 5184107 |
Total Current Liabilities | 40282 | 65032 | 68171 | 56574 | 44678 | 48849 |
Total Liabilities | 3427252 | 3499837 | 3829524 | 4254058 | 4578491 | 5316047 |
Fixed Assets | 13857 | 13838 | 3326 | 3372 | 3505 | 3672 |
Other Non-Current Assets | 3162214 | 3228647 | 3640754 | 4051842 | 4377313 | 5115276 |
Total Current Assets | 251181 | 257352 | 185444 | 198844 | 197673 | 197099 |
Total Assets | 3427252 | 3499837 | 3829524 | 4254058 | 4578491 | 5316047 |
#(Fig in Cr.) | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|
Opening Cash & Cash Equivalents | 58695 | 67906 | 63194 | 36118 | 44866 | 45588 |
Cash Flow from Operating Activities | 13274 | 54367 | 80602 | -3783 | 54519 | 26122 |
Cash Flow from Investing Activities | 8765 | -41809 | 148792 | 12099 | -54472 | -25400 |
Cash Flow from Financing Activities | -13700 | -18664 | -256125 | 0 | -949 | -4427 |
Net Cash Inflow / Outflow | 8339 | -6106 | -26731 | 8316 | -902 | -3706 |
Closing Cash & Cash Equivalent | 67906 | 63194 | 36118 | 44866 | 45588 | 42014 |
# | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|
Earnings Per Share (Rs) | 4.15 | 4.29 | 4.7 | 6.52 | 0 | 0 |
CEPS(Rs) | 4.15 | 4.29 | 4.7 | 6.52 | 56.91 | 64.69 |
DPS(Rs) | 4.2 | 4.3 | 0 | 1.5 | 3 | 10 |
Book NAV/Share(Rs) | 1.56 | 1.72 | 10.91 | 17.96 | 73.59 | 131.37 |
Core EBITDA Margin(%) | -66.98 | -68.62 | -70.19 | -64.5 | -56.37 | -70.28 |
EBIT Margin(%) | 0.78 | 0.71 | 0.74 | 0.97 | 7.58 | 8.61 |
Pre Tax Margin(%) | 0.78 | 0.71 | 0.74 | 0.97 | 7.58 | 8.61 |
PAT Margin (%) | 0.77 | 0.71 | 0.73 | 0.96 | 7.56 | 8.58 |
Cash Profit Margin (%) | 0.77 | 0.71 | 0.73 | 0.96 | 7.56 | 8.58 |
ROA(%) | 0.08 | 0.08 | 0.08 | 0.1 | 0.83 | 0.84 |
ROE(%) | 266.49 | 261.64 | 74.46 | 45.16 | 124.33 | 63.13 |
ROCE(%) | 0.98 | 1.04 | 2.28 | 45.59 | 124.62 | 63.34 |
Receivable days | 0 | 0 | 0 | 0 | 0 | 0 |
Inventory Days | 0 | 0 | 0 | 0 | 0 | 0 |
Payable days | 0 | 0 | 0 | 0 | 0 | 0 |
PER(x) | 0 | 0 | 0 | 0 | 0 | 0 |
Price/Book(x) | 0 | 0 | 0 | 0 | 7.27 | 6.96 |
Dividend Yield(%) | 0 | 0 | 0 | 0 | 0.56 | 1.09 |
EV/Net Sales(x) | -0.2 | -0.16 | -0.09 | -0.09 | 0.61 | 1.13 |
EV/Core EBITDA(x) | -21.59 | -93.19 | -2.62 | -2.15 | 6.24 | 11.93 |
Net Sales Growth(%) | 0 | 12.5 | 5.99 | 5.95 | 10.82 | 0.18 |
EBIT Growth(%) | 0 | 2.88 | 9.72 | 39.62 | 766.38 | 13.79 |
PAT Growth(%) | 0 | 3.16 | 9.73 | 38.69 | 772.71 | 13.67 |
EPS Growth(%) | 0 | 3.16 | 9.73 | 38.69 | -100 | 0 |
Debt/Equity(x) | 0 | 0 | 0 | 0 | 0 | 0 |
Current Ratio(x) | 4.12 | 3 | 2.23 | 2.78 | 3.32 | 3.09 |
Quick Ratio(x) | 4.12 | 3 | 2.23 | 2.78 | 3.32 | 3.09 |
Interest Cover(x) | 0 | 0 | 0 | 0 | 0 | 0 |
Total Debt/Mcap(x) | 0 | 0 | 0 | 0 | 0 | 0 |
# | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 96.5 | 96.5 | 96.5 | 96.5 | 96.5 | 96.5 | 96.5 | 96.5 | 96.5 | 96.5 |
FII | 0.12 | 0.18 | 0.17 | 0.08 | 0.08 | 0.1 | 0.06 | 0.15 | 0.19 | 0.15 |
DII | 1.06 | 0.91 | 0.92 | 0.89 | 0.83 | 0.84 | 1 | 0.86 | 0.94 | 1.16 |
Public | 2.32 | 2.42 | 2.42 | 2.53 | 2.59 | 2.56 | 2.44 | 2.49 | 2.37 | 2.18 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
# | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 610.36 | 610.36 | 610.36 | 610.36 | 610.36 | 610.36 | 610.36 | 610.36 | 610.36 | 610.36 |
FII | 0.78 | 1.12 | 1.05 | 0.51 | 0.52 | 0.62 | 0.4 | 0.92 | 1.21 | 0.96 |
DII | 6.69 | 5.73 | 5.8 | 5.66 | 5.26 | 5.34 | 6.31 | 5.46 | 5.95 | 7.36 |
Public | 14.67 | 15.29 | 15.29 | 15.97 | 16.36 | 16.19 | 15.42 | 15.76 | 14.98 | 13.81 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 632.5 | 632.5 | 632.5 | 632.5 | 632.5 | 632.5 | 632.5 | 632.5 | 632.5 | 632.5 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Sell or Purchase Share (Tentative Price)
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
You May Also Know About